Clinical trial
Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of…
NCT00148278 · University of Versailles, Other · Completed
Key facts
| NCT number | NCT00148278 |
|---|---|
| Title | Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock |
| Official title | Prospective, Multicenter, Randomized, Double-Blind Study Comparing Safety and Efficacy of Norepinephrine Plus Dobutamine Versus Epinephrine Alone in Septic Shock. |
| Acronym | CATS |
| Lead sponsor | University of Versailles, Other |
| Collaborators | Assistance Publique - Hôpitaux de Paris |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Septic Shock, Severe Sepsis, Infections |
| Intervention type | Drug |
| Interventions | norepinephrine and dobutamine, epinephrine plus placebo of dobutamine |
| Enrollment | 330 |
| Start date | Oct 1, 1999 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Sep 7, 2005 |
| Last update posted | Jul 22, 2010 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: